Pricing Log in Create free account
Friday 6 November 2026 Export ACAD’s income statement to Excel — free account

ACADIA Pharmaceuticals Inc.

ACAD Healthcare Biotechnology

ACADIA Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 11.9% from fiscal 2024.

Revenue
+22.9%
EPS
−27.9%
Free cash flow
+141.2%

Quarter to September 2026, against a year earlier

21.23 0.01 −0.05%
Market cap
$3.7B
P/E
10.0×
Fwd P/E
33.4×
Dividend yield
—
F-score
6/9
Altman Z
7.90
Beneish M
−0.89
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

ACADIA Pharmaceuticals Inc. (ACAD) P/B ratio

Alert me on P/B ratio

As of 6 November 2026, ACADIA Pharmaceuticals Inc. (ACAD) trades at a P/B ratio of 2.6×. Over the past ten years it has ranged from 2.3× (October 2026) to 19.7× (July 2015); the current reading is higher than 1% of that period. That is above the Biotechnology industry median of 2.0× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 3.7× (11.71%)
FY2024 4.1× (64.56%)
FY2023 11.7× 77.68%
FY2022 6.6× (4.84%)
FY2021 6.9× (48.37%)
FY2020 13.4× 48.93%
FY2019 9.0× 110.82%
FY2018 4.3× (61.60%)
FY2017 11.1× 73.06%
FY2016 6.4× (64.20%)

Quarterly newest first

Period P/B ratio Change
Sep 2026 2.5× (24.59%)
Jun 2026 3.3× 9.26%
Mar 2026 3.0× (16.99%)
Dec 2025 3.7× (6.73%)
43 more quarters

Against its own ten years

Low 2.3× High 19.7×
Ten-year median 8.0×
Current reading's percentile 1

P/B ratio against peers

Company P/B ratio
PBLS Parabilis Medicines, Inc. compare 0.8×
ACAD ACADIA Pharmaceuticals Inc. 2.6×
XENE Xenon Pharmaceuticals Inc. compare 3.0×
TNGX Tango Therapeutics, Inc. compare 3.1×
RLAY Relay Therapeutics, Inc. compare 3.9×
DYN Dyne Therapeutics, Inc. compare 4.1×
IOVA Iovance Biotherapeutics, Inc. compare 4.3×
IRON Disc Medicine, Inc. compare 4.7×
VKTX Viking Therapeutics, Inc. compare 5.2×
Biotechnology industry median 2.0×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on ACAD